CCA
MRK icon

Cora Capital Advisors’s Merck MRK Stock Holding History

Cora Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Buy
4,994
+24
+0.5% +$2.81K 0.18% 63
2026
Q1 		$598K Buy
4,970
+96
+2% +$11.1K 0.2% 62
2025
Q4 		$513K Buy
4,874
+241
+5% +$22.6K 0.2% 65
2025
Q3 		$389K Sell
4,633
-710
-13% -$58.5K 0.17% 68
2025
Q2 		$423K Buy
5,343
+125
+2% +$9.94K 0.19% 63
2025
Q1 		$468K Buy
5,218
+65
+1% +$6.07K 0.22% 65
2024
Q4 		$513K Buy
5,153
+42
+0.8% +$4.33K 0.25% 61
2024
Q3 		$580K Sell
5,111
-4
-0.1% -$475 0.29% 56
2024
Q2 		$633K Buy
5,115
+17
+0.3% +$2.19K 0.33% 51
2024
Q1 		$673K Buy
5,098
+27
+0.5% +$3.33K 0.36% 50
2023
Q4 		$553K Buy
5,071
+240
+5% +$24.9K 0.33% 53
2023
Q3 		$497K Buy
4,831
+92
+2% +$9.92K 0.33% 52
2023
Q2 		$547K Buy
4,739
+371
+8% +$42.1K 0.36% 52
2023
Q1 		$465K Buy
4,368
+90
+2% +$9.72K 0.35% 48
2022
Q4 		$475K Buy
+4,278
New +$437K 0.33% 46

Other funds holding MRK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Cora Capital Advisors's MRK Position: Q2 2026 in Review

Cora Capital Advisors increased its Merck (MRK) stake by 0.48% in Q2 2026, buying an estimated $2.81K and bringing the position to 4,994 shares worth $642K. The position accounts for 0.18% of the portfolio, ranked #63.

Cora Capital Advisors first reported a position in MRK in Q4 2022 and has held it in 15 quarters since. The position peaked at $673K in Q1 2024. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Cora Capital Advisors held 4,994 shares of Merck worth $642K as of Q2 2026.
  • Cora Capital Advisors bought 24 Merck shares in Q2 2026, an estimated $2.81K.
  • Merck made up 0.18% of Cora Capital Advisors's portfolio in Q2 2026, its #63 holding.
  • Cora Capital Advisors first reported a position in Merck in Q4 2022 and has held it in 15 quarters since.
  • Cora Capital Advisors's Merck position peaked at $673K in Q1 2024.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Cora Capital Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.